mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |